长药控股 (300391.SZ)

今开: 最高: 成交量:

昨收: 最低: 成交额:

+ 收藏

财务分析(报告期)(长药控股)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
    显示选项
关 闭
完整财报对比
2024年一季报2023年年报2023年三季报2023年中报2023年一季报2022年年报2022年三季报2022年中报2022年一季报
主要指标:
 营业收入(元) 59,091,762.311,197,562,401.161,021,867,556.56476,013,480.79136,792,880.941,615,322,934.591,422,647,907.32991,850,427.82545,403,773.14
 营业利润(元) -77,433,335.93-669,709,380.68-195,505,588.16-124,220,108.82-31,872,538.9779,945,821.33135,826,772.4650,934,044.7251,542,466.00
 利润总额(元) -81,120,269.42-681,010,132.28-115,402,835.34-43,460,116.86-31,925,795.1971,825,696.35133,671,135.3449,210,033.0851,248,802.93
 净利润(元) -81,120,269.42-707,334,505.63-137,591,259.61-37,604,542.07-30,813,220.7244,572,133.73103,109,145.5114,568,284.1550,233,749.76
 归属于母公司股东的净利润(元) -47,505,902.27-605,653,315.00-115,852,394.22-24,215,061.46-22,958,141.64-23,273,315.4927,425,057.22-40,275,664.4814,645,911.14
盈利能力:
 销售毛利率(%) 7.5916.3715.9316.528.1421.4722.2922.9725.28
 销售净利率(%) -137.28-59.06-13.46-7.90-22.532.767.251.479.21
 净资产收益率(%) -10.27-121.64-15.06-3.10-2.84----
 总资产报酬率ROA(%) -1.94-17.65-1.57-0.57-0.54----
 投入资本回报率ROIC(%) -4.59-43.06-7.01-1.40-1.33-1.321.53-2.140.78
营运能力:
 存货周转率(次) 0.8717.999.712.891.09----
 应收账款周转率(次) 0.040.780.670.370.10----
 总资产周转率(次) 0.020.340.280.120.03----
偿债能力:
 资产负债率(%) 72.7270.4857.6054.8055.4653.4853.0262.0562.07
 股东权益比率(%) 4.305.6618.3020.8021.2022.3723.2418.3719.22
 已获利息倍数(倍) -5.53-10.17-1.01-1.10-2.132.424.702.764.39
 流动比率 1.081.131.101.131.121.131.281.001.04
 速动比率 0.981.040.970.810.931.011.130.770.84
发展能力:
 营业收入增长率(%) -56.80-25.86-28.17-52.01-74.92-31.61-21.76-23.56-30.53
 营业利润增长率(%) -142.95-937.70-243.94-343.88-161.84-54.81-30.90-68.61-53.85
 税后利润增长率(%) -106.92-2,502.35-522.4339.88-256.75-147.40-71.64-147.95-75.35
 净资产增长率(%) -81.02-75.63-19.75-1.22-7.50-3.10-2.38-8.770.52
 总资产增长率(%) -6.44-3.711.93-12.78-16.16-15.09-14.19-0.90-8.26

前瞻产业研究院